Skip to main content
OpenTrials
Completed

NCT Number: NCT02173041

Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User

Substance Use Disorder has been showing a rising trend all over the world including India. The project tested whether a Integrated community wide effort of Prevention and Awareness Groups (PAG) to manage substance use would have a greater effect on treatment attendance and drug abstinence than a de-addiction program alone.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

GyanSanjeevani

Bai, Nawalgarh, Rajasthan, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • suburban, rural Population
  • Drug and/or alcohol dependency (DSM-IV substance use disorders criteria)

Exclusion criteria

  • Did not consent to participate
  • Planning to move or relocate
  • Severe mental disorder

Treatment and study plan

Prevention Awareness Groups (PAG)

Other

Standard care

Other

Primary outcomes

  1. Treatment attendance

    Time frame: Change from baseline to six month

Secondary outcomes

  1. Drug abstinence

    Time frame: Change from baseline to six month

Other outcomes

  1. Quality of Life assessed by General Health Questionnaire (GHQ)

    Time frame: Change from baseline to six months

Sponsors and collaborators

Lead sponsor

Macmillan Research Group UK

Industry

Collaborators

  • NMP Medical Research Institute
  • Warwick Research Services

Registry information

Official study title

Impact of Prevention Awareness Group (PAG) on Treatment Attendance and Drug Abstinence Among Substance User: Results of the Randomized Controlled Trial

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jun 24, 2014
Registry last updated
May 18, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.